Selected research
Market Structure
Global Acetaminophen-Opioid Combination Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Acetaminophen-Opioid Combination market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Acetaminophen-Opioid Combination is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Acetaminophen-Opioid Combination is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Acetaminophen-Opioid Combination is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Acetaminophen-Opioid Combination is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Acetaminophen-Opioid Combination include AstraZeneca, Endo Pharmaceuticals, Grünenthal, Hamilton Kent., Laboratoire Riva, Mallinckrodt Pharmaceuticals, Purdue Pharmaceuticals, Trio Remedies and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Acetaminophen-Opioid Combination market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Acetaminophen-Opioid Combination and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Acetaminophen-Opioid Combination revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Acetaminophen-Opioid Combination market size, projected growth trends, production technologies, key applications, and end-use industries.
Acetaminophen-Opioid Combination Segment by Company
AstraZeneca
Endo Pharmaceuticals
Grünenthal
Hamilton Kent.
Laboratoire Riva
Mallinckrodt Pharmaceuticals
Purdue Pharmaceuticals
Trio Remedies
Johnson & Johnson
Teva Pharmaceutical
Abbott
Acetaminophen-Opioid Combination Segment by Type
Tramadol/Acetaminophen
Hydrocodone/Acetaminophen
Oxycodone/Acetaminophen
Codeine/Acetaminophen
Others
Acetaminophen-Opioid Combination Segment by Application
Acute Pain
Chronic Pain
Others
Acetaminophen-Opioid Combination Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acetaminophen-Opioid Combination market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acetaminophen-Opioid Combination and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acetaminophen-Opioid Combination.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Acetaminophen-Opioid Combination in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Acetaminophen-Opioid Combination industry.
Chapter 3: Detailed analysis of Acetaminophen-Opioid Combination companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acetaminophen-Opioid Combinationrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tramadol/Acetaminophen
- Hydrocodone/Acetaminophen
- Oxycodone/Acetaminophen
- Codeine/Acetaminophen
- Others
Applications
- Acute Pain
- Chronic Pain
- Others
Companies covered
- AstraZeneca
- Endo Pharmaceuticals
- Grünenthal
- Hamilton Kent.
- Laboratoire Riva
- Mallinckrodt Pharmaceuticals
- Purdue Pharmaceuticals
- Trio Remedies
- Johnson & Johnson
- Teva Pharmaceutical
- Abbott
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Acetaminophen-Opioid Combination Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Tramadol/Acetaminophen
- 1.2.3 Hydrocodone/Acetaminophen
- 1.2.4 Oxycodone/Acetaminophen
- 1.2.5 Codeine/Acetaminophen
- 1.2.6 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Acetaminophen-Opioid Combination Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Acute Pain
- 1.3.3 Chronic Pain
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Acetaminophen-Opioid Combination Growth Trends by Region
- 1.5.1 Global Acetaminophen-Opioid Combination Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Acetaminophen-Opioid Combination Market Size by Region (2021-2026)
- 1.5.3 Acetaminophen-Opioid Combination Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Acetaminophen-Opioid Combination Market Dynamics
- 2.1 Acetaminophen-Opioid Combination Industry Trends
- 2.2 Acetaminophen-Opioid Combination Industry Drivers
- 2.3 Acetaminophen-Opioid Combination Industry Opportunities and Challenges
- 2.4 Acetaminophen-Opioid Combination Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Acetaminophen-Opioid Combination Revenue by Company (2021-2026)
- 3.2 Global Acetaminophen-Opioid Combination Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Acetaminophen-Opioid Combination Key Company Head office and Area Served
- 3.4 Global Acetaminophen-Opioid Combination Company, Product Type & Application
- 3.5 Global Acetaminophen-Opioid Combination Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Acetaminophen-Opioid Combination Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Acetaminophen-Opioid Combination Players Market Share by Revenue in 2025
- 3.6.3 2025 Acetaminophen-Opioid Combination Tier 1, Tier 2, and Tier 3
4 Acetaminophen-Opioid Combination Market by Type
- 4.1 Global Acetaminophen-Opioid Combination Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Acetaminophen-Opioid Combination Market Size by Type (2021-2032)
- 4.3 Global Acetaminophen-Opioid Combination Market Size Share by Type (2021-2032)
5 Acetaminophen-Opioid Combination Market by Application
- 5.1 Global Acetaminophen-Opioid Combination Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Acetaminophen-Opioid Combination Market Size by Application (2021-2032)
- 5.3 Global Acetaminophen-Opioid Combination Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 AstraZeneca
- 6.1.1 AstraZeneca Company Information
- 6.1.2 AstraZeneca Business Overview
- 6.1.3 AstraZeneca Acetaminophen-Opioid Combination Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 AstraZeneca Acetaminophen-Opioid Combination Product Portfolio
- 6.1.5 AstraZeneca Recent Developments
- 6.2 Endo Pharmaceuticals
- 6.2.1 Endo Pharmaceuticals Company Information
- 6.2.2 Endo Pharmaceuticals Business Overview
- 6.2.3 Endo Pharmaceuticals Acetaminophen-Opioid Combination Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Endo Pharmaceuticals Acetaminophen-Opioid Combination Product Portfolio
- 6.2.5 Endo Pharmaceuticals Recent Developments
- 6.3 Grünenthal
- 6.3.1 Grünenthal Company Information
- 6.3.2 Grünenthal Business Overview
- 6.3.3 Grünenthal Acetaminophen-Opioid Combination Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Grünenthal Acetaminophen-Opioid Combination Product Portfolio
- 6.3.5 Grünenthal Recent Developments
- 6.4 Hamilton Kent.
- 6.4.1 Hamilton Kent. Company Information
- 6.4.2 Hamilton Kent. Business Overview
- 6.4.3 Hamilton Kent. Acetaminophen-Opioid Combination Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Hamilton Kent. Acetaminophen-Opioid Combination Product Portfolio
- 6.4.5 Hamilton Kent. Recent Developments
- 6.5 Laboratoire Riva
- 6.5.1 Laboratoire Riva Company Information
- 6.5.2 Laboratoire Riva Business Overview
- 6.5.3 Laboratoire Riva Acetaminophen-Opioid Combination Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Laboratoire Riva Acetaminophen-Opioid Combination Product Portfolio
- 6.5.5 Laboratoire Riva Recent Developments
- 6.6 Mallinckrodt Pharmaceuticals
- 6.6.1 Mallinckrodt Pharmaceuticals Company Information
- 6.6.2 Mallinckrodt Pharmaceuticals Business Overview
- 6.6.3 Mallinckrodt Pharmaceuticals Acetaminophen-Opioid Combination Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Mallinckrodt Pharmaceuticals Acetaminophen-Opioid Combination Product Portfolio
- 6.6.5 Mallinckrodt Pharmaceuticals Recent Developments
- 6.7 Purdue Pharmaceuticals
- 6.7.1 Purdue Pharmaceuticals Company Information
- 6.7.2 Purdue Pharmaceuticals Business Overview
- 6.7.3 Purdue Pharmaceuticals Acetaminophen-Opioid Combination Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Purdue Pharmaceuticals Acetaminophen-Opioid Combination Product Portfolio
- 6.7.5 Purdue Pharmaceuticals Recent Developments
- 6.8 Trio Remedies
- 6.8.1 Trio Remedies Company Information
- 6.8.2 Trio Remedies Business Overview
- 6.8.3 Trio Remedies Acetaminophen-Opioid Combination Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Trio Remedies Acetaminophen-Opioid Combination Product Portfolio
- 6.8.5 Trio Remedies Recent Developments
- 6.9 Johnson & Johnson
- 6.9.1 Johnson & Johnson Company Information
- 6.9.2 Johnson & Johnson Business Overview
- 6.9.3 Johnson & Johnson Acetaminophen-Opioid Combination Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Johnson & Johnson Acetaminophen-Opioid Combination Product Portfolio
- 6.9.5 Johnson & Johnson Recent Developments
- 6.10 Teva Pharmaceutical
- 6.10.1 Teva Pharmaceutical Company Information
- 6.10.2 Teva Pharmaceutical Business Overview
- 6.10.3 Teva Pharmaceutical Acetaminophen-Opioid Combination Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Teva Pharmaceutical Acetaminophen-Opioid Combination Product Portfolio
- 6.10.5 Teva Pharmaceutical Recent Developments
- 6.11 Abbott
- 6.11.1 Abbott Company Information
- 6.11.2 Abbott Business Overview
- 6.11.3 Abbott Acetaminophen-Opioid Combination Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Abbott Acetaminophen-Opioid Combination Product Portfolio
- 6.11.5 Abbott Recent Developments
7 North America
- 7.1 North America Acetaminophen-Opioid Combination Market Size (2021-2032)
- 7.2 North America Acetaminophen-Opioid Combination Market Size by Type
- 7.2.1 North America Acetaminophen-Opioid Combination Market Size by Type (2021-2026)
- 7.2.2 North America Acetaminophen-Opioid Combination Market Size by Type (2027-2032)
- 7.2.3 North America Acetaminophen-Opioid Combination Market Share by Type (2021-2032)
- 7.3 North America Acetaminophen-Opioid Combination Market Size by Application
- 7.3.1 North America Acetaminophen-Opioid Combination Market Size by Application (2021-2026)
- 7.3.2 North America Acetaminophen-Opioid Combination Market Size by Application (2027-2032)
- 7.3.3 North America Acetaminophen-Opioid Combination Market Share by Application (2021-2032)
- 7.4 North America Acetaminophen-Opioid Combination Market Size by Country
- 7.4.1 North America Acetaminophen-Opioid Combination Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Acetaminophen-Opioid Combination Market Size by Country (2021-2026)
- 7.4.3 North America Acetaminophen-Opioid Combination Market Size by Country (2027-2032)
- 7.4.4 North America Acetaminophen-Opioid Combination Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Acetaminophen-Opioid Combination Market Size (2021-2032)
- 8.2 Europe Acetaminophen-Opioid Combination Market Size by Type
- 8.2.1 Europe Acetaminophen-Opioid Combination Market Size by Type (2021-2026)
- 8.2.2 Europe Acetaminophen-Opioid Combination Market Size by Type (2027-2032)
- 8.2.3 Europe Acetaminophen-Opioid Combination Market Share by Type (2021-2032)
- 8.3 Europe Acetaminophen-Opioid Combination Market Size by Application
- 8.3.1 Europe Acetaminophen-Opioid Combination Market Size by Application (2021-2026)
- 8.3.2 Europe Acetaminophen-Opioid Combination Market Size by Application (2027-2032)
- 8.3.3 Europe Acetaminophen-Opioid Combination Market Share by Application (2021-2032)
- 8.4 Europe Acetaminophen-Opioid Combination Market Size by Country
- 8.4.1 Europe Acetaminophen-Opioid Combination Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Acetaminophen-Opioid Combination Market Size by Country (2021-2026)
- 8.4.3 Europe Acetaminophen-Opioid Combination Market Size by Country (2027-2032)
- 8.4.4 Europe Acetaminophen-Opioid Combination Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Acetaminophen-Opioid Combination Market Size (2021-2032)
- 9.2 China Acetaminophen-Opioid Combination Market Size by Type
- 9.2.1 China Acetaminophen-Opioid Combination Market Size by Type (2021-2026)
- 9.2.2 China Acetaminophen-Opioid Combination Market Size by Type (2027-2032)
- 9.2.3 China Acetaminophen-Opioid Combination Market Share by Type (2021-2032)
- 9.3 China Acetaminophen-Opioid Combination Market Size by Application
- 9.3.1 China Acetaminophen-Opioid Combination Market Size by Application (2021-2026)
- 9.3.2 China Acetaminophen-Opioid Combination Market Size by Application (2027-2032)
- 9.3.3 China Acetaminophen-Opioid Combination Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Acetaminophen-Opioid Combination Market Size (2021-2032)
- 10.2 Asia Acetaminophen-Opioid Combination Market Size by Type
- 10.2.1 Asia Acetaminophen-Opioid Combination Market Size by Type (2021-2026)
- 10.2.2 Asia Acetaminophen-Opioid Combination Market Size by Type (2027-2032)
- 10.2.3 Asia Acetaminophen-Opioid Combination Market Share by Type (2021-2032)
- 10.3 Asia Acetaminophen-Opioid Combination Market Size by Application
- 10.3.1 Asia Acetaminophen-Opioid Combination Market Size by Application (2021-2026)
- 10.3.2 Asia Acetaminophen-Opioid Combination Market Size by Application (2027-2032)
- 10.3.3 Asia Acetaminophen-Opioid Combination Market Share by Application (2021-2032)
- 10.4 Asia Acetaminophen-Opioid Combination Market Size by Country
- 10.4.1 Asia Acetaminophen-Opioid Combination Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Acetaminophen-Opioid Combination Market Size by Country (2021-2026)
- 10.4.3 Asia Acetaminophen-Opioid Combination Market Size by Country (2027-2032)
- 10.4.4 Asia Acetaminophen-Opioid Combination Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Acetaminophen-Opioid Combination Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Acetaminophen-Opioid Combination Market Size by Type
- 11.2.1 South America, Middle East & Africa Acetaminophen-Opioid Combination Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Acetaminophen-Opioid Combination Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Acetaminophen-Opioid Combination Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Acetaminophen-Opioid Combination Market Size by Application
- 11.3.1 South America, Middle East & Africa Acetaminophen-Opioid Combination Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Acetaminophen-Opioid Combination Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Acetaminophen-Opioid Combination Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Acetaminophen-Opioid Combination Market Size by Country
- 11.4.1 South America, Middle East & Africa Acetaminophen-Opioid Combination Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Acetaminophen-Opioid Combination Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Acetaminophen-Opioid Combination Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Acetaminophen-Opioid Combination Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst